Phase I Trial of O6 Benzylguanine and BCNU in Cutaneous T-cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2013
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 10 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual number of patients (21) added as reported by ClinicalTrials.gov record.